Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Whilst injectable GLP-1 therapies such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda) are well established in UK clinical practice, transdermal patch formulations represent an emerging area of pharmaceutical development
Medicare patients can click here to find out more about the Medicare GLP-1 Bridge Program
Zepbound and Saxenda are approved for weight management, and Mounjaro and Victoza are approved by the FDA for type 2 diabetes management
This program is not intended to diagnose, treat, cure, or prevent any disease
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
